JPRN-UMIN000002285已完成2 期
The evaluation of the efficacy and safety on Bortezomib and Dexamethasone (BD therapy) using auto-PBSCT treatment after Vincristine,Doxorubicin and examethasone (VAD treatment) registanced multiple myeloma patients.(JMSG-0901) - Evolution of efficacy and safety on high-dose-chemotherapy using auto-PBSCT for symptomatic multiple myeloma.(JMSG-0901)
Japanese Society of Myeloma0 个研究点目标入组 40 人开始时间: 2009年8月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) There is a previous history of hypersensitivity for, Bortezomib the Doxorubicin, the Dexamethasone, the mannitol or boron. 2) Myeloma and plasma cell leukemia of nonsecreted form. 3) Case from whom amalgamation of nuclear power plant AL amyloidosis is doubted. 4) Case who has peripheral neuropathy of Grade 2 or more. 5) Patient of HIV antibody positivity, hepatitis B surface antigen positivity, and HCV antibody positivity. 6) There are a defective liver dysfunction to control, a renal dysfunction, a depressed ventricular function, a pulmonic impairment, a diabetic, high blood pressure, and an infectious disease. 7) It is briskness and a double cancer of the progress period (Simultaneity repetition cancer and a healthy period are the cancer of repetition of different time within five years. However, the considerable Carcinoma in Situ change to a morbid state in the neck of womb, the stomach, and the large intestine judged to be a recovery by the limited part treatment is not included in the double cancer of briskness). 8) A certain patient of serious illness such as schizophrenia. mental trouble. 9) Case pregnant woman and possibility getting pregnant and suckling during examination period. 10) The case (Consult if necessary with a special doctor such as respiratory organs) who admits an abnormal shadow of the quality (state of frosted glass and line shadow) among both sides on chest CT (high resolution CT) regardless of the presence of the case who has the lungs flame (interstitial pneumonia) and the pulmonary fibrosis in the clinical finding or the symptom. 11) Additionally, case who judged doctor in charge targets and it is improper.
研究者
相似试验
招募中
4 期
A Safety and Efficacy study of BOTOX® (Botulinum Toxin Type A) in patients with Urinary Incontinence due to bladder conditions.CTRI/2015/11/006353Allergan Healthcare India Pvt Ltd250
进行中（未招募）
不适用
A Study Evaluating the Efficacy and Safety of BOTOX® and Solifenacin in Patients with Overactive Bladder and Urinary IncontinenceOveractive Bladder and Urinary IncontinenceMedDRA version: 17.0Level: LLTClassification code 10059617Term: Overactive bladderSystem Organ Class: 100000004857EUCTR2012-003255-11-CZAllergan Limited345
进行中（未招募）
不适用
A Study Evaluating the Efficacy and Safety of BOTOX® and Solifenacin in Patients with Overactive Bladder and Urinary IncontinenceOveractive Bladder and Urinary IncontinenceMedDRA version: 14.1Level: LLTClassification code 10059617Term: Overactive bladderSystem Organ Class: 100000004857EUCTR2012-003255-11-GBAllergan Limited345
进行中（未招募）
不适用
A Study Evaluating the Efficacy and Safety of BOTOX® and Solifenacin in Patients with Overactive Bladder and Urinary IncontinenceEUCTR2012-003255-11-BEAllergan Limited345
进行中（未招募）
1 期
A Study Evaluating the Efficacy and Safety of BOTOX® and Solifenacin in Patients with Overactive Bladder and Urinary IncontinenceOveractive Bladder and Urinary IncontinenceMedDRA version: 17.1Level: LLTClassification code 10059617Term: Overactive bladderSystem Organ Class: 100000004857EUCTR2012-003255-11-DEAllergan Limited345